Genetic disruption of the autism spectrum disorder risk gene PLAUR induces GABAA receptor subunit changes.
Disruption of the GABAergic system has been implicated in multiple developmental disorders, including epilepsy, autism spectrum disorder and schizophrenia. The human gene encoding uPAR (PLAUR) has been shown recently to be associated with the risk of autism. The uPAR(-/-) mouse exhibits a regionally-selective reduction in GABAergic interneurons in frontal and parietal regions of the cerebral cortex as well as in the CA1 and dentate gyrus subfields of the hippocampus. Behaviorally, these mice exhibit increased sensitivity to pharmacologically-induced seizures, heightened anxiety, and atypical social behavior. Here, we explore potential alterations in GABAergic circuitry that may occur in the context of altered interneuron development. Analysis of gene expression for 13 GABA(A) receptor subunits using quantitative real-time polymerase chain reaction (PCR) indicates seven subunit mRNAs (alpha(1), alpha(2), alpha(3), beta(2), beta(3), gamma(2S) and gamma(2L)) of interest. Semi-quantitative in situ hybridization analysis focusing on these subunit mRNAs reveals a complex pattern of potential gene regulatory adaptations. The levels of alpha(2) subunit mRNAs increase in frontal cortex, CA1 and CA3, while those of alpha3 decrease in frontal cortex and CA1. In contrast, alpha(1) subunit mRNAs are unaltered in any region examined. beta(2) subunit mRNAs are increased in frontal cortex whereas beta(3) subunit mRNAs are decreased in parietal cortex. Finally, gamma(2S) subunit mRNAs are increased in parietal cortex while gamma(2L) subunit mRNAs are increased in the dentate gyrus, potentially altering the gamma(2S):gamma(2L) ratio in these two regions. For all subunits, no changes were observed in forebrain regions where GABAergic interneuron numbers are normal. We propose that disrupted differentiation of GABAergic neurons specifically in frontal and parietal cortices leads to regionally-selective alterations in local circuitry and subsequent adaptive changes in receptor subunit composition. Future electrophysiological studies will be useful in determining how alterations in network activity in the cortex and hippocampus relate to the observed behavioral phenotype.
Eagleson
K L
KL
Zilkha Neurogenetic Institute and Department of Cell and Neurobiology, Keck School of Medicine at University of Southern California, 1501 San Pablo Street, Los Angeles, CA 90033, USA. keagleso@usc.edu
Gravielle
M C
MC
Schlueter McFadyen-Ketchum
L J
LJ
Russek
S J
SJ
Farb
D H
DH
Levitt
P
P
D000818:Animals; D002648:Child; D002659:Child Development Disorders, Pervasive / Q000235:genetics*; D006801:Humans; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D021122:Protein Subunits / Q000096:biosynthesis / Q000235:genetics; D012333:RNA, Messenger / Q000096:biosynthesis; D011963:Receptors, GABA-A / Q000096:biosynthesis* / Q000235:genetics; D055293:Receptors, Urokinase Plasminogen Activator / Q000235:genetics / Q000502:physiology*; D013687:Telencephalon / Q000378:metabolism*
C524899:Plaur protein, mouse; D021122:Protein Subunits; D012333:RNA, Messenger; D011963:Receptors, GABA-A; D055293:Receptors, Urokinase Plasminogen Activator
J Pharmacol Exp Ther. 1997 Oct;283(1):350-7
9336343
J Chem Neuroanat. 2001 Jul;22(1-2):95-100
11470557
Am J Psychiatry. 2008 Apr;165(4):479-89
18281411
J Neurosci. 2003 Dec 17;23(37):11711-24
14684873
Neuroscience. 2007 Dec 5;150(2):370-85
17950542
Int Rev Neurobiol. 2007;78:109-31
17349859
Hum Mol Genet. 2007 Mar 15;16(6):691-703
17339270
J Biol Chem. 1992 Jul 15;267(20):14470-6
1321150
Hum Mol Genet. 2005 Feb 15;14(4):483-92
15615769
J Comp Neurol. 2003 Dec 22;467(4):581-92
14624490
J Neurochem. 1994 Jul;63(1):301-9
8207435
Neuropsychopharmacology. 2003 Nov;28(11):1950-9
12888776
J Neurosci. 2003 Jul 16;23(15):6315-26
12867516
Biol Psychiatry. 2009 Jun 15;65(12):1015-23
19249749
J Comp Neurol. 2005 Sep 5;489(4):449-66
16025458
Science. 2004 Mar 12;303(5664):1678-81
15017001
Mol Cell Neurosci. 2007 Jun;35(2):220-9
17433713
J Neurosci. 2009 Aug 26;29(34):10695-705
19710321
Ann Neurol. 2001 Jan;49(1):67-78
11198298
Mol Psychiatry. 2008 Feb;13(2):147-61
17471287
Neuroreport. 2003 Sep 15;14(13):1731-5
14512847
Mol Pharmacol. 1995 Nov;48(5):861-8
7476917
J Child Neurol. 2006 Dec;21(12):1058-63
17156698
Biol Psychiatry. 2008 May 15;63(10):953-62
17988653
Neuroimage. 2004 May;22(1):22-8
15109994
Arch Gen Psychiatry. 2000 Mar;57(3):237-45
10711910
Am J Hum Genet. 2005 Sep;77(3):377-88
16080114
Am J Med Genet B Neuropsychiatr Genet. 2004 Nov 15;131B(1):51-9
15389768
Pharmacol Biochem Behav. 2000 Jun;66(2):371-4
10880692
Nat Neurosci. 2005 Aug;8(8):1059-68
16007083
J Neural Transm (Vienna). 2002 May;109(5-6):881-9
12111475
Epilepsia. 2005;46 Suppl 7:22-8
16201992
Neuropharmacology. 1996;35(9-10):1457-63
9014161
Autism Res. 2009 Aug;2(4):205-19
19650112
Ann Hum Genet. 2006 May;70(Pt 3):281-92
16674551
Neuron. 1994 May;12(5):1081-95
8185945
J Neurosci. 2008 Feb 20;28(8):1904-15
18287507
Pharmacol Biochem Behav. 2000 Aug;66(4):887-92
10973530
Dev Biol. 2008 Jan 15;313(2):648-58
18054781
Nat Med. 1998 Oct;4(10):1166-72
9771750
Neuron. 2009 Aug 27;63(4):466-81
19709629
Physiol Behav. 2002 Dec;77(4-5):595-600
12527005
Proc Natl Acad Sci U S A. 2006 Mar 14;103(11):4275-80
16537521
Neuroscience. 2005;132(2):399-407
15802192
Neuropediatrics. 2003 Aug;34(4):169-76
12973656
Cereb Cortex. 2006 Jan;16(1):47-63
15829735
Mol Cell Neurosci. 2003 Oct;24(2):442-50
14572465
Neuroscience. 1999;93(1):33-44
10430468
Int J Neuropsychopharmacol. 2008 Nov;11(7):891-903
18364065
Proc Natl Acad Sci U S A. 2009 Apr 7;106(14):5942-7
19293383
Cell Tissue Res. 2006 Nov;326(2):505-16
16937111
Cereb Cortex. 2009 Jul;19 Suppl 1:i22-31
19366869
Cereb Cortex. 2002 Oct;12(10):1063-70
12217970
Epilepsia. 2006 Oct;47(10):1655-64
17054688
Brain. 2006 Dec;129(Pt 12):3277-89
17046856
J Neurosci. 1994 Sep;14(9):5302-24
8083738
Neuroscience. 2005;134(2):691-704
15951123
Trends Neurosci. 2004 Jul;27(7):400-6
15219739
Brain Res. 2007 Apr 6;1140:75-83
16996039
Proc Natl Acad Sci U S A. 1990 Dec;87(24):9966-70
1702226
Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):15066-71
9844016
J Neurodev Disord. 2009 Sep;1(3):224-36
19816534
Cereb Cortex. 1995 Nov-Dec;5(6):550-60
8590827
J Neurosci. 2002 Apr 1;22(7):2718-29
11923437
Nat Neurosci. 2009 Aug;12(8):1020-7
19620975
Thromb Haemost. 2007 Mar;97(3):336-42
17334498
Brain Res. 2004 Jul 30;1016(1):1-11
15234246
Curr Opin Neurobiol. 2007 Feb;17(1):103-11
17275283
Nat Neurosci. 2005 Jun;8(6):797-804
15895085
Hippocampus. 2000;10(3):305-24
10902900
Brain Res. 2006 Nov 22;1121(1):238-45
17046729
Autism Res. 2008 Jun;1(3):159-68
19360663
J Neurosci. 2009 Jul 8;29(27):8752-63
19587282
Nat Rev Neurosci. 2005 Apr;6(4):312-24
15803162
Nat Neurosci. 1998 Nov;1(7):563-71
10196563
J Neurobiol. 2002 Feb 5;50(2):137-49
11793360
J Neurosci. 2003 Jan 15;23(2):622-31
12533622
Science. 2004 Mar 12;303(5664):1681-3
15017002
Neuroscience. 1997 Jul;79(2):477-87
9200730
Neuroscience. 1999;91(1):327-41
10336082
Eur J Pharmacol. 2002 Jun 20;446(1-3):201-2
12098603
Psychopharmacology (Berl). 2005 Jul;180(2):191-205
15864560
J Med Genet. 2006 May;43(5):429-34
16556609
Genes Brain Behav. 2003 Oct;2(5):255-67
14606691
Behav Brain Res. 2010 Jan 5;206(1):32-7
19716847